Patents by Inventor Patrick Gutschow

Patrick Gutschow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200300873
    Abstract: The present invention is generally related to kits for measuring a level of hepcidin in a biological sample in an in vitro assay compared to a standard control. The kits may further include instructions for use, a label for use, or both. The kits may be used to identify an individual having a disease or disorder associated with an elevated level of hepcidin, a reduced level of hepcidin, an elevated level of iron, a reduced level of iron, or a combination thereof.
    Type: Application
    Filed: November 21, 2016
    Publication date: September 24, 2020
    Inventors: Mark Westerman, Patrick Gutschow, Vaughn Ostland
  • Patent number: 10239941
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: March 26, 2019
    Assignee: Intrinsic Lifesciences LLC
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Publication number: 20180057586
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Application
    Filed: August 31, 2017
    Publication date: March 1, 2018
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Patent number: 9803011
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: October 31, 2017
    Assignee: Intrinsic Lifesciences LLC
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Publication number: 20170283495
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Application
    Filed: April 11, 2017
    Publication date: October 5, 2017
    Inventors: Mark WESTERMAN, Vaughn OSTLAND, Huiling HAN, Patrick GUTSCHOW, Keith WESTERMAN, Gordana OLBINA
  • Patent number: 9657098
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: May 23, 2017
    Assignee: INTRINSIC LIFESCIENCES, LLC
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Publication number: 20160017032
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 21, 2016
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina